Neuromodulation Therapies Overview

Principles

Definition

Neuromodulation therapies is a multidisciplinary research field and methodological approach dedicated to understanding and applying targeted interventions that alter neural activity. It encompasses the study of mechanisms by which electrical or chemical stimuli modulate specific neural circuits within the central, peripheral, or autonomic nervous systems. The field investigates the development, optimization, and clinical translation of these techniques as therapeutic modalities for managing diverse neurological and chronic conditions, representing a major advance in clinical treatment strategies.

Ontological type

Clinical Indications

Core Modalities

Mechanisms of Action

Key developments

Key Figures

Foundational Invasive Stimulation era

E. Jankowska [1] was active across Rockefeller University [3] and the University of Glasgow [4] during the Foundational Invasive Stimulation era. Her 1967 paper 'The Effect of DOPA on the Spinal Cord 5. Reciprocal organization of pathways transmitting excitatory action to alpha motoneurones of flexors and extensors' [7] contributed key insights into the organization of spinal excitability and excitatory pathways, laying groundwork for localization and reproducible readouts in invasive stimulation research. Anders Björklund [2] worked across the University of California, San Francisco [5] and Stanford University [6] in this era. His 1987 paper 'Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum' [8] advanced understanding of how intracerebral implants interact with subcortical circuits, informing design and interpretation of chronic stimulation approaches.

Field-Targeted Noninvasive Modulation era

Walter Paulus [1], with positions at Medical University of Vienna [3] and Ludwig-Maximilians-Universität München [4], exemplifies the Field-Targeted Noninvasive Modulation era. Paulus [1] contributed key findings across three papers—Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans [7], Pharmacological Modulation of Cortical Excitability Shifts Induced by Transcranial Direct Current Stimulation in Humans [8], and Partially non-linear stimulation intensity-dependent effects of direct current stimulation on motor cortex excitability in humans [9]—that linked stimulation dose, waveform, and pharmacology to LTP/LTD-like plasticity and inhibitory circuit engagement, guiding parameterization and safety for focal noninvasive modulation. Michael A. Nitsche [2], affiliated with University of Cambridge [5] and Scuola Internazionale Superiore di Studi Avanzati [6], likewise helped shape this translational field. Nitsche [2] contributed to the same trio of studies [7][8][9], underscoring how dose, waveform, and pharmacology drive lasting excitability changes and informing clinical translation and safety frameworks for targeted noninvasive stimulation.

Adaptive Network-Guided Modulation era

Zhenan Bao [1] is associated with Massachusetts Institute of Technology [3] and Stanford University [4]. The paper Soft and elastic hydrogel-based microelectronics for localized low-voltage neuromodulation [7] demonstrates soft, compliant interfaces enabling localized, low-power neuromodulation, a key capability for adaptive, network-guided modulation. Jill L. Ostrem [2] is affiliated with University Memory and Aging Center [5] and University of California, San Francisco [6]. The paper Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease [8] shows that deep brain stimulation can modulate network-level dynamics, a foundational insight for network-aware neuromodulation.